← Leaderboards
Frank C. Sciurba
University Of Pittsburgh At Pittsburgh
$26,390,698
Attributed
$49,008,278
Total exposure
15
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $9.8M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$58,916,709 · 15
AHRQ$2,909,478 · 1
By mechanism
P50$19,495,937 · 4
U01$18,832,181 · 2
RC2$11,401,676 · 1
N01$4,181,353 · 3
U18$2,909,478 · 1
R01$2,850,797 · 1
Top collaborators
- Panagiotis V Benos7 shared
- Stephen R Wisniewski6 shared
- Howard B Degenholtz3 shared
- Mark W Geraci3 shared
- Naftali Kaminski3 shared
- Alison Morris3 shared
- John Quackenbush3 shared
- David Albert Schwartz3 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Robert L Ferris$24,076,317
- Jennifer R Grandis$109,711,044
- Lina Ghaloul-Gonzalez$910,360
- Surinder Kumar Batra$34,830,369
- David Tom Huang$5,966,166
Others in their field
Top investigators on “Chronic Obstructive Airway Disease”
- James D Crapo · University Of Colorado Denver$90,851,150
- Edwin K Silverman · Brigham And Women'S Hospital$66,435,690
- Prescott G Woodruff · University Of California San Francisco$44,725,610
- Bryan O Buchholz · University Of Massachusetts Lowell$40,621,016
- David D. McManus · Univ Of Massachusetts Med Sch Worcester$40,621,016
- Jane Wilkinson · Broad Institute, Inc.$38,181,500
Research focus
Chronic Obstructive Airway DiseaseResearch PersonnelPhysiologicalCohortLungCollaborationsClassificationInnovationProgramsCharacteristicsBaseComplexEnsureMolecularPulmonary EmphysemaMeasurementDisease ProgressionClinical DataTissuesPhenotypeEnrollmentEvaluationStructure Of Parenchyma Of LungFuture
Grant awards (57)
The Pitt IMProving Access to Culturally relevant long COVID care and Treatment (IMPACCT) Program$965,315
U18 · FY2025 · HS
The Pitt IMProving Access to Culturally relevant long COVID care and Treatment (IMPACCT) Program$964,230
U18 · FY2024 · HS
COPD SUBTYPES AND EARLY PREDICTION USING INTEGRATIVE PROBABILISTIC GRAPHICAL MODELS R01HL157879$682,134
R01 · FY2024 · HL
The Pitt IMProving Access to Culturally relevant long COVID care and Treatment (IMPACCT) Program$979,933
U18 · FY2023 · HS
COPD SUBTYPES AND EARLY PREDICTION USING INTEGRATIVE PROBABILISTIC GRAPHICAL MODELS R01HL157879$705,300
R01 · FY2023 · HL
COPD SUBTYPES AND EARLY PREDICTION USING INTEGRATIVE PROBABILISTIC GRAPHICAL MODELS R01HL157879$723,608
R01 · FY2022 · HL
COPD SUBTYPES AND EARLY PREDICTION USING INTEGRATIVE PROBABILISTIC GRAPHICAL MODELS$739,755
R01 · FY2021 · HL
Network Management Core (NEMO) for the Pulmonary Trials Cooperative (PTC)$4,291,369
U01 · FY2019 · HL
Systems Level Causal Discovery in Heterogeneous TOPMed Data$602,448
U01 · FY2019 · HL
Systems Level Causal Discovery in Heterogeneous TOPMed Data$601,486
U01 · FY2018 · HL
Network Management Core (NEMO) for the Pulmonary Trials Cooperative (PTC)$1
U01 · FY2018 · HL
Network Management Core (NEMO) for the Pulmonary Trials Cooperative (PTC)$3,785,748
U01 · FY2017 · HL
Systems Level Causal Discovery in Heterogeneous TOPMed Data$607,934
U01 · FY2017 · HL
Network Management Core (NEMO) for the Pulmonary Trials Cooperative (PTC)$4,297,492
U01 · FY2016 · HL
Network Management Core (NEMO) for the Pulmonary Trials Cooperative (PTC)$248,401
U01 · FY2016 · HL
Biomarkers predictive of Lung Function Decline in physiologically Normal Smokers$231,000
R21 · FY2016 · HL · contact PI
Long-term Oxygen Treatment Trial$9,754
N01 · FY2016 · HL · contact PI
Network Management Core (NEMO) for the Pulmonary Trials Cooperative (PTC)$4,397,302
U01 · FY2015 · HL
Biomarkers predictive of Lung Function Decline in physiologically Normal Smokers$192,500
R21 · FY2015 · HL · contact PI
Long-Term Oxygen Treatment Trial (LOTT) - Regional Clinical Center$156,803
N01 · FY2015 · HL · contact PI
LTRC CLINICAL CENTER$506,237
N01 · FY2013 · HL · contact PI
Long-Term Oxygen Treatment Trial (LOTT) - Regional Clinical Center$396,523
N01 · FY2013 · HL · contact PI
Molecular and Cellular Determinants of Disease Heterogeneity in COPD$2,578,270
P50 · FY2012 · HL · contact PI
Peripheral Markers of Phenotypic Heterogeneity in COPD$813,487
P50 · FY2012 · HL · contact PI
LTRC CLINICAL CENTER$712,833
N01 · FY2012 · HL · contact PI
Clinical$371,549
P50 · FY2012 · HL · contact PI
Long-term Oxygen Treatment Trial$211,555
N01 · FY2012 · HL · contact PI
Administrative$143,178
P50 · FY2012 · HL · contact PI
LTRC CLINICAL CENTER$713,712
N01 · FY2011 · HL · contact PI
Lung Genomics Research Consortium$3,759,656
RC2 · FY2010 · HL
Molecular and Cellular Determinants of Disease Heterogeneity in COPD$2,569,890
P50 · FY2010 · HL · contact PI
Lung Genomics Research Consortium$1,654,805
RC2 · FY2010 · HL
Peripheral Markers of Phenotypic Heterogeneity in COPD$805,516
P50 · FY2010 · HL · contact PI
Clinical$373,041
P50 · FY2010 · HL · contact PI
Administrative$142,856
P50 · FY2010 · HL · contact PI
Long-term Oxygen Treatment Trial$25,000
N01 · FY2010 · HL · contact PI
Lung Genomics Research Consortium$5,987,215
RC2 · FY2009 · HL
Molecular and Cellular Determinants of Disease Heterogeneity in COPD$2,538,101
P50 · FY2009 · HL · contact PI
Peripheral Markers of Phenotypic Heterogeneity in COPD$806,075
P50 · FY2009 · HL · contact PI
Clinical$373,894
P50 · FY2009 · HL · contact PI
Administrative$142,329
P50 · FY2009 · HL · contact PI
Molecular and Cellular Determinants of Disease Heterogeneity in COPD$2,515,856
P50 · FY2008 · HL · contact PI
Peripheral Markers of Phenotypic Heterogeneity in COPD$807,934
P50 · FY2008 · HL · contact PI
Clinical$367,883
P50 · FY2008 · HL · contact PI
Administrative$139,247
P50 · FY2008 · HL · contact PI
Molecular and Cellular Determinants of Disease Heterogeneity in COPD$2,615,792
P50 · FY2007 · HL · contact PI
Peripheral Markers of Phenotypic Heterogeneity in COPD$843,751
P50 · FY2007 · HL · contact PI
Clinical$376,703
P50 · FY2007 · HL · contact PI
Administrative$170,585
P50 · FY2007 · HL · contact PI
COPD Clinical Research Network$116,008
U10 · FY2007 · HL · contact PI
COPD Clinical Research Network$524,185
U10 · FY2006 · HL · contact PI
COPD Clinical Research Network$734,800
U10 · FY2005 · HL
LUNG TISSUE RESEARCH CONSORTIUM (LTRC): CLINICAL CENTER$1,332
M01 · FY2005 · RR
COPD Clinical Research Network$336,116
U10 · FY2004 · HL
Feasibility of Retinoid Therapy for Emphysema (FORTE)$18,824
M01 · FY2004 · RR
FEASIBILITY STUDIES ON RETINOID TREATMENT IN EMPHYSEMA$1,211,913
N01 · FY2000 · HR
FEASIBILITY STUDIES ON RETINOID TREATMENT IN EMPHYSEMA$237,023
N01 · FY2000 · HR